Preview

Nephrology (Saint-Petersburg)

Advanced search

Electrolyte concentration in blood serum as prognostic of severe course COVID-19

https://doi.org/10.36485/1561-6274-2022-26-1-27-33

Abstract

THE AIM. To study the key homeostatic physicochemical parameters of blood serum characterizing the patient's state with COVID-19 of varying severity. Patients and methods. The study involved 94 patients with COVID-19, age from 24 to 102 years, median – 67 years, men – 43, women – 51. Patients were divided into 3 groups: 1st – 40 patients with a relatively mild course, 2nd – 22 patients with a severe course of the disease, after treatment they were discharged from the clinic, the 3rd – 32 patients with a very severe course of COVID-19 and a fatal outcome. The concentration of ions in blood serum was measured on a Gem Premier 3000 (Instrumentation Laboratory, USA), clinical analysis was performed on a BC-5380c Mindray hematology analyzer (Mindray, China), biochemical studies were performed on an Architech c4000 analyzer (Abbott Laboratories, USA).
RESULTS. The harbingers of a serious impairment in patients with COVID-19 were an increase in the Na+/K+ ratio in blood serum from 32,7±0,8 to 44,7 ± 2.1 (p<0,01), a decrease in the concentration of ionized Ca2+ from 1,08 ± 0,01 to 0,9 ± 0,03 mmol/l (p<0,01), a sharp increase in the concentration of C-reactive protein from 43,6±8,6 to 175 ± 14,7 mg/l (p<0,01). Within the reference values with COVID-19 the concentration of bilirubin and creatinine in the blood serum remained normal; the concentration of total protein was at the lower limits of the normal range, the glucose level was slightly higher than normal, and ferritin was increased compared to the reference values.
CONCLUSION. Harbingers of a sharp impairment in COVID-19 are an increase in the Na+/K+ ratio in the blood serum, a decrease of the of ionized Ca2+ concentration, a sharp increase in C-reactive protein concentration.

About the Authors

Yu. V. Natochin
I.M. Sechenov Insitute of Evolutionary Physiology and Bioсhemistry Russian Academy of Sciences
Russian Federation

Prof. Yurij V. Natochin MD, PhD, Acad. RAS, Chief Researcher of Laboratory of Renal physiology

194223, St. Petersburg, M. Thorez pr., 44.

Phone: (812)5523086 



O. B. Chernyshev
City Hospital of the Holy Great Martyr George
Russian Federation

Oleg B. Chernyshev MD, PhD

Saint-Petersburg

Tel.: 8(812)5765050 



References

1. Бобкова СС, Жуков АА Проценко ДН и др. Критический анализ концепции «цитокиновой бури» у пациентов с новой коронавирусной инфекцией Covid-19. Обзор литературы. Вестник интенсивной терапии им. А.И. Салтанова 2021; 1:57–68 Bobkova SS, Zhukov AA Protsenko DN et al. Critical analysis of the “cytokine storm” concept in patients with novel coronavirus infection Covid-19. Literature review. Bulletin of Intensive Care. A.I. Saltanova 2021; 1:57–68 (in Russ.) doi: 10.21320/1818-474X-2021-1-57-68

2. Machhi N, Herskovitz J, Senan AM et al. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J Neuroimmune Pharmacol 2020; 15(3):359–386. doi: 10.1007/s11481-020-09944-5

3. Добронравов ВА, Ватазин АВ, Смирнов АВ и др. Нефрологическая служба в условиях пандемии COVID-19 (позиция Ассоциации нефрологов). Нефрология 2021; 25(1):9–17 Dobronravov VA, Vatazin AV, Smirnov AV et al. Renal service during the COVID-19 pandemic (Association of nephrologists position statement). Nephrology (Saint-Petersburg) 2021;25(1):9–17 (In Russ.) https://doi.org/10.36485/1561-6274-2021-25-1-9-17

4. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science 2020; 368 (6490):473–474. doi: 10.1126/science.abb8925

5. Perico L, Benigni A, Casiraghi F et al. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol 2021; 17(1):46–64. doi: 10.1038/s41581-020-00357-4

6. Бахарев СД, Бауло ЕВ, Быкова СВ и др. COVID-19 и тонкая кишка. Тер арх 2021; 93(3):343–347 Bakharev SD, Baulo EV, Bykova SV et al. COVID-19 and the small intestine. Ter arch 2021; 93(3):343–347 (in Russ.) doi: 10.26442/00403660.2021.03.200662

7. Мнацаканян МГ, Погромов АП, Лишута АС и др. Механизмы повреждения печени при COVID-19. Тер арх 2021; 93(4):427–430 Mnatsakanyan MG, Pogromov AP, Lishuta AS et al. Mechanisms of liver damage in COVID-19. Ter arch 2021; 93(4):427–430 (in Russ.) doi: 10.26442/00403660.2021.04.200733

8. Chen D, Li X, Song Q, Hu C et al. Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China. JAMA Netw Open 2020; 3(6):e2011122. doi: 10.1001/jamanetworkopen.2020.11122

9. Mabillard H, Sayer JA. Electrolyte Disturbances in SARS-CoV-2 Infection. F1000Research 2020; 9:587(1-14). doi: 10.12688/f1000research.24441.2

10. Moreno-PO, Leon-Ramirez J-M, Fuertes-Kenneally L et al. Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients. Int J Infect Dis 2020; 100:449–454. doi: 10.1016/j.ijid.2020.09.033

11. Huang I, Pranata R, Lim MA et al. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis 2020; 14:1753466620937175. doi: 10.1177/1753466620937175

12. Kermali M, Khalsa RK, Pillai K, et al. The role of biomarkers in diagnosis of COVID-19 – A systematic review. Life Sci 2020; 254:117788. doi: 10.1016/j.lfs.2020.117788

13. Mosquera Sulbaran JA, Pedreañez A, Carrero Y, et al. Creactive protein as an effector molecule in Covid-19 pathogenesis. Rev Med Virol 2021; e2221. doi: 10.1002/rmv.2221

14. Moutchia J, Pokharel P, Kerri A et al. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. PLoS One 2020; 15(10): e0239802. doi: 10.1371/journal.pone.0239802

15. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (Covid-19). Министерство здравоохранения РФ. Версия 11 (07.05.2021). 225 с Interim guidelines. Prevention, diagnosis and treatment of novel coronavirus infection (Covid-19). Ministry of Health of the Russian Federation. Version 11 (05/07/2021). 225 p (in Russian)]

16. Шейман Дж. Патофизиология почки. Пер. с англ. Бином, М., Невский диалект, СПб., 2019. 190 с. Sheiman J. Pathophysiology of the kidney. / Per. from English. Binom, M., Nevsky dialect, St. Petersburg, 2019. 190 p. (in Russ.)

17. Наточин ЮВ, Мухин НА. Введение в нефрологию. ГЭОТАР-Медиа, М., 2007. 149 с. Natochin YuV, Mukhin NA. Introduction to Nephrology. GEOTAR-Media, M., 2007. 149 p (in Russ.)

18. Majumder J, Minko T. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19. AAPS J 2021; 23(14):1–22. doi: 10.1208/s12248-020-00532-21


Review

For citations:


Natochin Yu.V., Chernyshev O.B. Electrolyte concentration in blood serum as prognostic of severe course COVID-19. Nephrology (Saint-Petersburg). 2022;26(1):27-33. (In Russ.) https://doi.org/10.36485/1561-6274-2022-26-1-27-33

Views: 1149


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)